Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
Emanuele
E
Sinagra
Ambrogio
A
Orlando
Sara
S
Renna
Marcello
M
Maida
Mario
M
Cottone
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000009:adverse effects*; D004351:Drug Resistance / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D011379:Prognosis; D017511:Pyoderma Gangrenosum / Q000139:chemically induced* / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069285:Infliximab